Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK‐700) in Healthy Male Subjects: A Phase 1, Open‐Label, Single‐Dose Study

Publisher: John Wiley & Sons Inc

E-ISSN: 2160-7648|5|3|180-187

ISSN: 2160-763X

Source: Clinical Pharmacology In Drug Development, Vol.5, Iss.3, 2016-05, pp. : 180-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content